Adiponectin Pathways in NASH Treatment Potential
Nonalcoholic steatohepatitis (NASH) represents a growing concern in liver health, sparking interest in innovative treatments. Adiponectin, a hormone with glucose-regulating and anti-inflammatory properties, emerges as a promising target. Examining its mechanisms, therapeutic potential, and pharmacological challenges illuminates new pathways for tackling NASH, offering hope for more effective management of this prevalent condition. Unlocking New Avenues […]
3 minute read